CRA International Inc (CRAI) Q4 2025 Earnings Call Transcript

Why It Matters

The upgraded guidance and higher dividend underscore CRA’s resilient business model and expanding global footprint, signaling stronger earnings potential for investors and heightened demand for economic consulting services.

Key Takeaways

• Revenue up 10.8% to $185.9M, record three‑quarter total
• International revenue jumps 30.3%, led by antitrust, life sciences
• Non‑GAAP EBITDA margin guidance raised to 12.6‑13%
• Dividend increased 16% to $0.57 per share
• Utilization steady at 77% despite modest headcount decline

Pulse Analysis

CRA International’s Q3 performance highlights the growing importance of specialized economic consulting in a volatile macro environment. The firm’s double‑digit revenue growth in antitrust, energy, finance and intellectual property practices reflects heightened client demand for data‑driven litigation support and strategic advisory. International expansion, especially in Europe, has accelerated as regulatory scrutiny intensifies, positioning CRA to capture higher‑margin cross‑border engagements. This geographic diversification reduces reliance on North American markets and aligns with broader industry trends where consultancies are leveraging global talent pools to address complex, multinational disputes.

The upgraded full‑year outlook—revenue of $740‑$748 million and an EBITDA margin of up to 13%—signals robust profitability despite modest headcount contraction. A 3% average bill‑rate increase and stable 77% utilization demonstrate effective pricing power and operational efficiency. For investors, the 16% dividend hike and continued share repurchases reinforce CRA’s commitment to returning capital, while ample liquidity and a $10.9 million repurchase capacity provide flexibility to navigate potential economic headwinds.

Looking ahead, CRA’s involvement in high‑profile transactions, such as UnitedHealth’s $3.3 billion Amedisys acquisition and Microsoft’s EU Teams investigation, showcases its capability to influence outcomes in large‑scale M&A and competition matters. As antitrust enforcement and transfer‑pricing disputes intensify worldwide, demand for expert economic analysis is likely to rise, offering CRA a clear growth runway. Companies seeking to mitigate regulatory risk and optimize strategic decisions will increasingly turn to firms like CRA, reinforcing the firm’s position as a leading player in the economic consulting space.